PREDiCT’s 3D Oncology Summit is all about showcasing the impact 3D models are having on IO and Oncology pipelines.
2018’s inaugural event saw over 80 leading scientists from 50+ different model-development and pharmaceutical organizations meet to define core criteria for the use of 3D tumor models.
This year, alongside fresh new case studies and speakers, discussions will address open questions to translatability, platform validity, alongside how additive technologies are presenting further opportunities for these models.
"The meeting was excellent. I was impressed with the array of highly relevant experts that were brought together to speak" - Merck, Associate Principal Scientist, PREDiCT 3D Oncology Attendee
"I really enjoyed the conference, and I learned a lot, both from presentations and informal interactions. Presentations were well balanced between science and technical innovation, and speakers focused on highlighting pros and cons of each application, which is helpful for someone just starting to explore the field of 3D models" -Jounce Therapeutics, PREDiCT 3D Models Attendee
